Efeito da formononetina (7 hidroxi, 4'metoxi isoflavona) na colonização micorrízica e crescimento do milho em solo contendo excesso de metais pesados

O excesso de metais pesados contamina o solo, exercendo impacto negativo sobre os microrganismos e ação tóxica sobre as plantas, dificultando a revegetação e reabilitação de áreas degradadas. No presente estudo, avaliou-se o efeito da aplicação do isoflavonóide formononetina (7 hidroxi, 4'metoxi isoflavona) no crescimento e absorção de metais pelo milho (Zea mayz L.) em mistura de solo com proporções crescentes de um solo contaminado que continha 16.904, 194, 219 e 836 mg dm-3 de solo de Zn, Cd, Pb e Cu, respectivamente. Esse solo foi diluído com solo não contaminado para obter misturas com 0; 2,5; 5,0; 7,5 e 10,0% p/p do solo contaminado. Nas misturas de solo, infestadas com propágulos de fungos micorrízicos, foi plantado milho, com e sem a aplicação de solução de formononetina sintética (5 mg L-1) equivalente a 400 µg kg-1 de solo. Verificou-se um efeito depressivo acentuado da elevação da contaminação do solo na colonização micorrízica e no crescimento das plantas. A formononetina estimulou a colonização nos níveis mais baixos de contaminação e exerceu efeito positivo no crescimento do milho. A absorção dos metais, em especial de Zn e Cd, aumentou com a elevação da contaminação, sendo os teores de Zn menores nas plantas com formononetina, enquanto os teores de Fe foram maiores nestas plantas até 7,5% de solo contaminado. Os resultados indicam que a formononetina reduz, de modo indireto, por meio da micorriza, os efeitos adversos do excesso de metais no solo, especialmente de Zn no milho. O favorecimento da formação de micorriza diminui a absorção de Zn e aumenta a de Fe, podendo ser este o mecanismo responsável pela ação amenizante da formononetina na toxidez de metais pesados no milho. Conclui-se que o uso da formononetina pode facilitar a revegetação de solos contaminados com metais pesados.

Entropy change and magnetocaloric effect in Gd5(SixGe1-x)4

Isothermal magnetization curves up to 23 T have been measured in Gd5Si1.8Ge2.2. We show that the values of the entropy change at the first-order magnetostructural transition, obtained from the Clausius-Clapeyron equation and the Maxwell relation, are coincident, provided the Maxwell relation is evaluated only within the transition region and the maximum applied field is high enough to complete the transition. These values are also in agreement with the entropy change obtained from differential scanning calorimetry. We also show that a simple phenomenological model based on the temperature and field dependence of the magnetization accounts for these results.

Entropy change and magnetocaloric effect in Gd5(SixGe1-x)4

Isothermal magnetization curves up to 23 T have been measured in Gd5Si1.8Ge2.2. We show that the values of the entropy change at the first-order magnetostructural transition, obtained from the Clausius-Clapeyron equation and the Maxwell relation, are coincident, provided the Maxwell relation is evaluated only within the transition region and the maximum applied field is high enough to complete the transition. These values are also in agreement with the entropy change obtained from differential scanning calorimetry. We also show that a simple phenomenological model based on the temperature and field dependence of the magnetization accounts for these results.

US 30 Proposed Expansion Benton County, Iowa, Enviornmental Assessment and Section 4(f) De Minimis Impact Finding, June 11, 2012

The Transportation Equity Act of the 21st Century (TEA-21) (23 CFR) mandated environmental streamlining in order to improve transportation project delivery without compromising environmental protection. In accordance with TEA-21, the environmental review process for this project has been documented as a Streamlined Environmental Assessment (EA). This document addresses only those resources or features that apply to the project. This allowed study and discussion of resources present in the study area, rather than expend effort on resources that were either not present or not impacted. Although not all resources are discussed in the EA, they were considered during the planning process and are documented in the Streamlined Resource Summary, shown in Appendix A. The following table shows the resources considered during the environmental review for this project. The first column with a check means the resource is present in the project area. The second column with a check means the impact to the resource warrants more discussion in this document. The other listed resources have been reviewed and are included in the Streamlined Resource Summary.

Continuous sunitinib treatment in patients with unresectable hepatocellular carcinoma (HCC): A multicenter phase II trial (SAKK 77/06 and SASL 23)

Background: Sunitinib (SU) is a multitargeted tyrosine kinase inhibitor with antitumor and antiangiogenetic activity. Evidence for clinical activity in HCC was reported in 2 phase II trials [Zhu et al and Faivre et al, ASCO 2007] using either a 37.5 or a 50 mg daily dose in a 4 weeks on, 2 weeks off regimen. The objective of this trial was to demonstrate antitumor activity of continuous SU treatment in patients (pts) with HCC. Methods: Key eligibility criteria included unresectable or metastatic HCC, no prior systemic anticancer treatment, measurable disease and Child- Pugh A or B liver dysfunction. Pts received 37.5 mg SU daily until progression or unacceptable toxicity. The primary endpoint was progression free survival at 12 weeks (PFS12) defined as 'success' if the patient was alive and without tumor progression assessed by 12 weeks (±7 days) after registration. A PFS12 of _20% was considered uninteresting and promising if _40%. Using the Simon-two minimax stage design with 90% power and 5% significance the sample size was 45 pts. Secondary endpoints included safety assessments, measurement of serum cobalamin levels and tumor density. Results: From September 2007 to August 2008 45 pts, mostly male (87%), were enrolled in 10 centers. Median age was 63 years, 89% had Child-Pugh A and 47% had distant metastases. Median largest lesion diameter was 84mm (range: 18-280) and 18% had prior TACE. Reasons for stopping therapy were: PD 60%, symptomatic deterioration 16%, toxicity 11%, death 2% (due to tumor), and other reasons 4%; 7% remain on therapy. PFS12 was rated as success in 15 pts (33%) (95% CI: 20%, 49%) and failure in 27 (60%); 3 were not evaluable (due to refusal). Over the whole trial period 1 CR and 40% SD as best response were achieved. Median PFS, duration of disease stabilization, TTP and OS were 2.8, 3.2, 2.8 and 9.3 months, respectively. Grade 3 and 4 adverse events were infrequent and all deaths due to the tumor. Conclusions: Continuous SU treatment with 37.5 mg/d daily is feasible and demonstrates moderate activity in pts with advanced HCC and mild to moderately impaired liver dysfunction. Under this trial design the therapy is considered promising (>13 PFS12 successes).

Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals.

OBJECTIVES: Toll-like receptors (TLRs) are innate immune sensors that are integral to resisting chronic and opportunistic infections. Mounting evidence implicates TLR polymorphisms in susceptibilities to various infectious diseases, including HIV-1. We investigated the impact of TLR single nucleotide polymorphisms (SNPs) on clinical outcome in a seroincident cohort of HIV-1-infected volunteers. DESIGN: We analyzed TLR SNPs in 201 antiretroviral treatment-naive HIV-1-infected volunteers from a longitudinal seroincident cohort with regular follow-up intervals (median follow-up 4.2 years, interquartile range 4.4). Participants were stratified into two groups according to either disease progression, defined as peripheral blood CD4(+) T-cell decline over time, or peak and setpoint viral load. METHODS: Haplotype tagging SNPs from TLR2, TLR3, TLR4, and TLR9 were detected by mass array genotyping, and CD4(+) T-cell counts and viral load measurements were determined prior to antiretroviral therapy initiation. The association of TLR haplotypes with viral load and rapid progression was assessed by multivariate regression models using age and sex as covariates. RESULTS: Two TLR4 SNPs in strong linkage disequilibrium [1063 A/G (D299G) and 1363 C/T (T399I)] were more frequent among individuals with high peak viral load compared with low/moderate peak viral load (odds ratio 6.65, 95% confidence interval 2.19-20.46, P < 0.001; adjusted P = 0.002 for 1063 A/G). In addition, a TLR9 SNP previously associated with slow progression was found less frequently among individuals with high viral setpoint compared with low/moderate setpoint (odds ratio 0.29, 95% confidence interval 0.13-0.65, P = 0.003, adjusted P = 0.04). CONCLUSION: This study suggests a potentially new role for TLR4 polymorphisms in HIV-1 peak viral load and confirms a role for TLR9 polymorphisms in disease progression.

4- ja 7-vuotiaan lapsen miksi-kysymykset aikuisen ja lapsen välisessä vuorovaikutuksessa

Summary

Report on a special investigation of Café DMACC within Des Moines Area Community College campus in Ankeny, Iowa for the period January 4, 2013 through May 2, 2014

Report on a special investigation of Café DMACC within Des Moines Area Community College campus in Ankeny, Iowa for the period January 4, 2013 through May 2, 2014

Finland mellan 'öst' och 'väst' - en jämförelse av 23 politiska system i EU

Abstract: Finland between th 'East' and the 'West' - comparison of political systems of 23 EU member states